Pumping a donor kidney with the LifePort Kidney Transporter preserves and protects the organ in a number of ways before it is transplanted. One of the most important features is the use of gentle, pulsatile pressure waves to ensure that cold preservation solution is circulated through the entire vasculature of the kidney in a way that counteracts the potentially damaging effects of ex vivo cold preservation.
In a kidney under normal physiological conditions at 37°C, the strong, sinusoidal pulse wave generated by the heart is dampened by the elasticity of the arteries, which leads to a weaker pulse wave passing through the microvasculature of the kidney.1 Because this dampening effect is greatly reduced in a hypothermic kidney, LifePort generates a gentle sinusoidal pulse wave to keep the pressure in the microvasculature the same as that found under normal physiological conditions. In addition, LifePort uses a microprocessor-controlled infusion pump to dynamically adjust the pressure wave to respond to decreases in renal resistance.
This unique design of the LifePort allows it to achieve the benefits of machine perfusion with lower pressures, thereby limiting the risk to the microvasculature of the kidney.
1. Baumann M, et al. Pulsatile stress correlates with (micro-) albuminuria in renal transplant recipients. Transpl Int 2009;23:292–298.
Check out the most recent posts
Novel Oxygenation Technique for Hypothermic Machine Perfusion of Liver Grafts: Validation in Porcine Donation after Cardiac Death (DCD) Liver Model
In a pre-clinical study using a porcine DCD model, Panayotova et al. sought to validate the novel technique of oxygen “pre-charge” for hypothermic machine perfusion (HMP) using the LifePort Liver Transporter. The study evaluated the effects of this preservation method...
David’s Transplant Journey
In this powerful video, we meet David, a liver recipient who shares his journey of needing a liver transplant. David speaks about the emotional and physical toll of waiting for a liver to become available, not knowing when or if he would receive that call. David takes...
Changing liver utilization and discard rates in clinical transplantation in the ex-vivo machine preservation era
A recent review article by Azizieh et al. focused on the implementation of ex-vivo machine preservation and how it might change the perception of organ acceptability. By focusing on machine perfusion, they explored the effects of the different modalities on outcomes...
Therapeutic Hypothermia or Hypothermic Machine Perfusion (HMP) which is best for Kidney Transplant Outcomes?
In 2023, Malinoski et al. published the results from a pragmatic, adaptive, prospective, randomized trial that was conducted between August 10, 2017, and May 21, 2020 involving six OPOs in the US. They sought to determine whether targeted mild hypothermia is as...